Surfing the NASH Tsunami hosts its Season 3 finale to celebrate a momentous year in Fatty Liver through a series of interviews with Key Opinion Leaders. For this second installment, Surfers Louise Campbell and Roger Green are joined by Jeff Lazarus to discuss a “drugs-plus” approach to liver disease, interprofessional collaboration, guidelines and much more.
Executive Director Veronica Miller joins guest Manal Abdelmalek and co-host Jörn Schattenberg (both Steering Committee members) to introduce the origins of the Liver Forum. This conversation goes on to explore an ongoing project aimed to develop research tools and metrics that can capture the richness available in a plethora of data emerging from NASH studies.
In this episode discussing the Liver Forum, Jörn Schattenberg, Manal Abdelmalek, Veronica Miller and Roger Green investigate how to study efficacy and safety in real time, using collective knowledge and experience with therapies for advancing liver disease. Jörn, Manal and Veronica each provide their unique introductions to the steering committee and elaborate on the Forum’s efforts toward moving the field forward.
The 73rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) takes place on November 4th-8th, 2022 in Washington DC. In this episode From the Vault, Manal Abdelmalek, Jörn Schattenberg and Ian Rowe join Stephen Harrison, Louise Campbell and Roger Green to promptly recap a just-concluded 2021 AASLD Annual Liver Meeting. Discussion centers around the many areas of advance and novelty in the program, with particular attention to non-invasive testing, genomics and the increased visibility of patients and their needs.
In Part 2 of this episode, host Roger Green interviews podcast friend and frequent guest, Dr. Jeffrey Lazarus. In this conversation, they discuss the NAFLD Nomenclature Conference held in July.
In a preview of Paris NASH and the NAFLD Summit 2022, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to discuss what each looks forward to in the upcoming meeting. Additionally in a part 2 of this episode, Prof. Jeff Lazarus from the Barcelona Institute for Global Health joins Roger for a one on one interview. Jeff shares a snapshot into what he has been working on over the past few months, as well as his anticipated interests on the NAFLD Summit agenda.
From May of this year, INCBCN 2022 co-chair Jeff Lazarus joins the Surfers (including co-chair Jörn Schattenberg) to discuss the recent conference in Barcelona. This conversation asks what “patient empowerment” means to Fatty Liver stakeholders.
Stephen Harrison leads a panel including the regular Surfers, Mazen Noureddin and Michelle Long through key elements of his presentation of the Phase 3 MAESTRO NAFLD-1 study at #ILC2022. He also shares information about an analysis of cirrhotic patients in the open-label cohort of the study.
Louise Campbell and Robert Mitchell-Thain discuss the world of NAFLD patients both in interacting with clinicians and in living their daily lives
Roger Green interviews physician, author, and entrepreneur Marcus Ranney about his experiences, the ability of data and digital health to empower health seekers, and the foundational vision that led him to form Human Edge and develop the Mito app.
Hepatologist Naim Alkhouri and Endocrinologist Scott Isaacs join Ken Cusi and Roger Green to discuss drug choices prescribers can make
